SCHEMBL25272444

SCHEMBL25272444

CN1CCN(Cc2cccc3c2CN(C2CCC(=O)NC2=O)C3=O)CC1

nearest known ligand 0.71

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 16/20 0.71
▸ IKZF3 Q9UKT9 13/20 0.71
▸ TNF P01375 4/20 0.61
▸ IL1B P01584 4/20 0.61
▸ IKZF1 Q13422 3/20 0.61
▸ DDB1 Q16531 2/20 0.61
▸ BRD4 O60885 1/20 0.61
▸ IKZF2 Q9UKS7 2/20 0.58
▸ CSNK1A1 P48729 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31076618 1.00 CRBN (0.71) CRBNIKZF3TNFIL1BIKZF1
SCHEMBL31077146 0.92 CRBN (0.61) CRBNIKZF3TNFIL1BIKZF1
SCHEMBL25236707 0.92 CRBN (0.61) CRBNIKZF3TNFIL1BIKZF1
SCHEMBL25221668 0.90 CRBN (0.62) CRBNIKZF3TNFIL1BIKZF1
SCHEMBL19585322 0.88 CRBN (0.64) CRBNIKZF3TNFIL1BIKZF1
SCHEMBL25226229 0.88 CRBN (0.61) CRBNIKZF3TNFIL1BIKZF1
SCHEMBL25235846 0.88 CRBN (0.58) CRBNIKZF3TNFIL1BIKZF1
SCHEMBL24967104 0.88 CRBN (0.63) CRBNIKZF3TNFIL1BIKZF1
SCHEMBL25276364 0.88 CRBN (0.65) CRBNIKZF3TNFIL1BIKZF1
SCHEMBL25236611 0.88 CRBN (0.62) CRBNIKZF3TNFIL1BIKZF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023104155-A1 LIGAND COMPOUNDS FOR E3 UBIQUITIN LIGASE, PROTEIN DEGRADERS DEVELOPED ON BASIS OF LIGAND COMPOUNDS, AND USES THEREOF 标新生物医药科技(上海)有限公司 2023-06-15 — — WO claimed
CN-116239566-A E3 ubiquitin ligase ligand compound, protein degradation agent developed based on ligand compound and application thereof 标新生物医药科技(上海)有限公司 2023-06-09 — — CN claimed
WO-2023104155-A1 LIGAND COMPOUNDS FOR E3 UBIQUITIN LIGASE, PROTEIN DEGRADERS DEVELOPED ON BASIS OF LIGAND COMPOUNDS, AND USES THEREOF 标新生物医药科技(上海)有限公司 2023-06-15 — — WO disclosed
Send feedback